U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Drug Depot, LLC., dba APS Pharmacy - 653740 - 10/11/2023
  1. Warning Letters


Drug Depot, LLC., dba APS Pharmacy MARCS-CMS 653740 —

Delivery Method:
VIA Electronic Mail

Recipient Name
Rob Kilgore
Recipient Title
Drug Depot, LLC., dba APS Pharmacy
Belmar Pharma Solutions

12860 W. Cedar Drive, Suite 211
Lakewood, CO 80228
United States

Issuing Office:
Division of Pharmaceutical Quality Operations II

United States

Dear Mr. Kilgore:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [Case #653740] issued on March 31, 2023, for Drug Depot, LLC dba APS Pharmacy, located at 34911 US Highway 19 N, Ste 600, Palm Harbor, FL 34684. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Ronda Loyd-Jones
Director, Compliance Branch
Office of Pharmaceutical Quality Operations,
Division II

cc: Via Electronic Mail
Anne Szilagyi, VP of Quality
Belmar Pharma Solutions
12860 W. Cedar Dr., Suite 211
Lakewood, CO 80228
Email: anne.szilagyi@belmarpharma.com

Andrew M. Vukadinovich
Director of Operations
Drug Depot, LLC., dba APS Pharmacy
34911 US Highway 19N, Ste 600
Palm Harbor, FL 34684-1921
Email: andyv@aspsmeds.com

Back to Top